Pricing Log in Create free account

Daxor Corporation (DXR) vs Nephros Inc. (NEPH)

Daxor Corporation and Nephros Inc. are both Medical Instruments & Supplies companies. Daxor Corporation is the larger, with a market value of $50.4M against $33.6M — 1.5× the size. Daxor Corporation trades at the lower P/E: 4.0× against 18.0×. Nephros Inc. grew revenue faster over the last twelve months: 20.4% against −52.1%. Nephros Inc. has the higher net margin (8.86% vs −251.9%) and the higher return on invested capital (14.3% vs 0.00%). Across the 17 metrics below, Nephros Inc. leads on 10 and Daxor Corporation on 7.

Valuation

Metric DXR NEPH Medical Instruments & Supplies median
P/E 4.01 17.98 30.28
P/S n/m 1.59 2.49
P/B 1.27 2.74 2.34
Price to free cash flow n/m n/m 23.49
EV/EBITDA n/m 15.32 14.87
EV/Sales (12.50) 1.38 2.75
Earnings yield 24.91% 5.56% 0.00%
Free cash flow yield (19.52%) (3.02%) 0.59%

Profitability

Metric DXR NEPH Medical Instruments & Supplies median
Gross margin 0.00% 60.55% 53.60%
Operating margin 0.00% 8.48% 1.97%
Net margin (251.91%) 8.86% 0.00%
Free cash flow margin 224.51% (4.22%) 2.36%
Return on equity 37.62% 16.95% 0.00%
Return on assets 35.90% 13.39% 0.00%
Return on invested capital 0.00% 14.29% 0.13%

Growth

Metric DXR NEPH Medical Instruments & Supplies median
Revenue growth (TTM) (52.06%) 20.36% 8.97%
EPS growth (last fiscal year) 7.63% 1,471.43% 6.51%
Revenue growth, 5-year CAGR 0.00% 17.02% 8.85%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DXR NEPH Medical Instruments & Supplies median
Debt to equity 0.00 0.00 0.10
Current ratio 1.66 5.50 2.47
Net debt to EBITDA 0.00 (4.20) 0.97

Dividend

Metric DXR NEPH Medical Instruments & Supplies median
Dividend yield — — 1.02%
Payout ratio — — 0.27

Size

Metric DXR NEPH Medical Instruments & Supplies median
Market cap 50.40m 33.59m 1.71b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack